Crossmark

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Crossref DOI link: https://doi.org/10.1038/nature23467

Published Online: 2017-07-19

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niewoehner, Ole

Garcia-Doval, Carmela

Rostøl, Jakob T.

Berk, Christian

Schwede, Frank

Bigler, Laurent

Hall, Jonathan

Marraffini, Luciano A.

Jinek, Martin
License Information

Text and Data Mining valid from 2017-07-19
More Information

Article History

Received: 20 June 2017

Accepted: 10 July 2017

First Online: 19 July 2017

Competing interests

: F.S. is an employee of BIOLOG Life Science Institute GmbH, which markets synthetic nucleotides. The other authors declare no competing financial interests.